Year: 2025
Type: article
Study design: Case Report
Abstract: This clinical case examines central retinal serous chorioretinopathy in a patient undergoing treatment with semaglutide. The subject of the case is a middle-aged male who developed this retinal condition following the administration of 14 mg of oral semaglutide. He reported a variety of vision-related disturbances that significantly impacted his daily activities. Fortunately, the visual impairments were completely resolved upon discontinuation of the medication. This case underscores the critical importance of vigilant ophthalmological monitoring for patients receiving semaglutide. It is imperative to monitor for any potential adverse effects on vision, thereby facilitating the prompt recognition and management of any changes or complications. By prioritizing regular eye examinations, healthcare providers can protect patients' visual health and promptly address any issues that may arise during their treatment.
Language: English
Topic: Drug-Induced Ocular Toxicity
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4411210190